STYLAGE XXL BI-SOFT LIDOCAINE

STYLAGE XXL BI-SOFT LIDOCAINE is a biodegradable gel:
- Based on hyaluronic acid, which stimulates the skin's natural long-term hydration.
- The mannitol distributes the gel evenly.
- Trace elements compensate for vitamin deficiencies that cause the dermis to sag.
- Bi-SOFT Injection Technology.

- VIVACY
- NAME: STYLAGE XXL BI-SOFT LIDOCAINE
- COMPOSITION: Cross-linked hyaluronic acid 21 mg/g, 0.3% Mepivacaine hydrochloride, Mannitol.
- PRESENTATION: 2 x 1 ml.
- NEEDLES: 2x 25G40mm; 2x 27G½; 1x 23G½.
- INDICATIONS: Indicated for the restoration and modelling of facial volumes and the correction of deep wrinkles and nasolabial folds.
- INJECTION DEPTH: Deep or subcutaneous dermis.
- DURATION: 12 to 18 months.
- USE: Strict medical use.

- Syringes: 2 x 1 ml.
- Needles: 2x 25G40mm; 2x 27G½; 1x 23G½.

Cheeks, chin, temples and wrinkles.

Cross-linked hyaluronic acid 21 mg/g, 0.3% Mepivacaine hydrochloride, Mannitol.

- The product must only be used by qualified medical personnel experienced in aesthetic medicine.
- Carry out a thorough medical history assessment of the patient prior to treatment, including allergies, current therapies and risk conditions.
- Avoid applying or administering the product in areas with active skin infections, dermatitis or irritation.
- Do not mix with other products or substances that are not expressly compatible.
- Observe the storage conditions and instructions for use specified by the manufacturer; use sterile, single-use materials where applicable.
- After treatment, inform the patient to avoid exposure to intense heat, direct UV radiation, vigorous massage or intense physical activity for the recommended period.
- Inform the patient about the possibility of transient local reactions (redness, slight swelling, tightness) and their management measures.

STYLAGE XXL BI-SOFT LIDOCAINE is contraindicated in the following cases:
- Known hypersensitivity or allergy to hyaluronic acid or any of the components of the product, including any excipients.
- Previous significant adverse reactions to injectable or transdermal hyaluronic acid treatments.
- Presence of active skin infections, inflammation, dermatitis or lesions in the area to be treated.
- Auto-immune diseases in active phase, immunodepression or conditions contraindicating medical-aesthetic treatment, unless assessed by a specialist.
- Pregnancy and lactation, unless otherwise advised by a doctor.
- Known coagulation disorders or unstabilised anticoagulant therapy.
- Patients under the age of the device's indications.

- Filling large volumetric defects, achieving exceptionally natural and long-lasting results
- Correcting unwanted concavities
- Highlight cheekbones
- Improving the shape of the mouth
- Restoring lip volume and proportion